Loading…
Anthrax post-vaccinal cell-mediated immunity in humans: kinetics pattern
Seven groups (2596 subjects) were vaccinated with a human live anthrax vaccine (HLAV) by three different routes (scarification, subcutaneous and aerosol). The vaccinees were tested for anthrax cell-mediated immunity using the “Anthraxin” skin test at 7, 15, 30, 90, 180 and 365 days following vaccina...
Saved in:
Published in: | Vaccine 1997-04, Vol.15 (6), p.631-636 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Seven groups (2596 subjects) were vaccinated with a human live anthrax vaccine (HLAV) by three different routes (scarification, subcutaneous and aerosol). The vaccinees were tested for anthrax cell-mediated immunity using the “Anthraxin” skin test at 7, 15, 30, 90, 180 and 365 days following vaccination. The kinetic pattern, obtained from all groups, shows a significant, five-phased curve: phase I (2–6 days post-vaccination) shows a slow increase in positive Anthraxin skin reactions. Phase II (7–15 days post-vaccination) shows an exponential rise to a maximum at day 15. Phase III (16–30 days post-vaccination) shows a decrease to day 30. Phase IV (31–90 days post-vaccination) leads to a relative restoration of the positive skin reactions. During phase V (91–365 days post-vaccination) there is a continuous decrease in positive Anthraxin skin reactions. The loss of the skin test reaction on day 30 is a characteristic feature of post-vaccination anthrax cell-mediated immunity. It may be due to a blockade of macrophages by lethal anthrax toxin released by the multiplying vaccine strain. Epidemiological observations of HLAV protective rates correlate with the phases of the skin reaction kinetics. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/S0264-410X(96)00286-1 |